WO2004080148A3 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides Download PDF

Info

Publication number
WO2004080148A3
WO2004080148A3 PCT/US2003/030720 US0330720W WO2004080148A3 WO 2004080148 A3 WO2004080148 A3 WO 2004080148A3 US 0330720 W US0330720 W US 0330720W WO 2004080148 A3 WO2004080148 A3 WO 2004080148A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
polypeptides
novel nucleic
novel
present
Prior art date
Application number
PCT/US2003/030720
Other languages
French (fr)
Other versions
WO2004080148A2 (en
Inventor
Y Tom Tang
Vinod Asundi
Feiyan Ren
Jie Zhang
Tom Wehrman
Zhiwei Wang
Yunqing Ma
Dunrui Wang
Rui-Hong Chen
Qing A Zhao
Jian-Rui Wang
Malabika Ghosh
Aidong J Xue
Gezhi Weng
Ping Zhou
Original Assignee
Nuvelo Inc
Y Tom Tang
Vinod Asundi
Feiyan Ren
Jie Zhang
Tom Wehrman
Zhiwei Wang
Yunqing Ma
Dunrui Wang
Rui-Hong Chen
Qing A Zhao
Jian-Rui Wang
Malabika Ghosh
Aidong J Xue
Gezhi Weng
Ping Zhou
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc, Y Tom Tang, Vinod Asundi, Feiyan Ren, Jie Zhang, Tom Wehrman, Zhiwei Wang, Yunqing Ma, Dunrui Wang, Rui-Hong Chen, Qing A Zhao, Jian-Rui Wang, Malabika Ghosh, Aidong J Xue, Gezhi Weng, Ping Zhou filed Critical Nuvelo Inc
Priority to AU2003303305A priority Critical patent/AU2003303305A1/en
Priority to EP03815295A priority patent/EP1556490A4/en
Priority to JP2004569415A priority patent/JP2006517094A/en
Priority to CA002500521A priority patent/CA2500521A1/en
Publication of WO2004080148A2 publication Critical patent/WO2004080148A2/en
Publication of WO2004080148A3 publication Critical patent/WO2004080148A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Abstract

The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.
PCT/US2003/030720 2002-10-02 2003-09-30 Novel nucleic acids and polypeptides WO2004080148A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2003303305A AU2003303305A1 (en) 2002-10-02 2003-09-30 Novel nucleic acids and polypeptides
EP03815295A EP1556490A4 (en) 2002-10-22 2003-09-30 Novel nucleic acids and polypeptides
JP2004569415A JP2006517094A (en) 2002-10-22 2003-09-30 Novel nucleic acids and polypeptides
CA002500521A CA2500521A1 (en) 2002-10-02 2003-09-30 Novel nucleic acids and polypeptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/416,186 2002-10-02
US41618602P 2002-10-22 2002-10-22

Publications (2)

Publication Number Publication Date
WO2004080148A2 WO2004080148A2 (en) 2004-09-23
WO2004080148A3 true WO2004080148A3 (en) 2005-03-31

Family

ID=32990311

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/030720 WO2004080148A2 (en) 2002-10-02 2003-09-30 Novel nucleic acids and polypeptides

Country Status (5)

Country Link
EP (1) EP1556490A4 (en)
JP (1) JP2006517094A (en)
AU (1) AU2003303305A1 (en)
CA (1) CA2500521A1 (en)
WO (1) WO2004080148A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209884D0 (en) 2002-04-30 2002-06-05 Ares Trading Sa Proteins
ATE528397T1 (en) * 2003-08-08 2011-10-15 Perseus Proteomics Inc GENE OVEREXPRESSED IN CANCER
US20070037204A1 (en) 2003-08-08 2007-02-15 Hiroyuki ABURANTAI Gene overexpressed in cancer
JP4634302B2 (en) * 2003-09-30 2011-02-16 第一三共株式会社 Tetrahydrofolate synthase gene
DE602004026898D1 (en) 2003-10-10 2010-06-10 Deutsches Krebsforsch COMPOSITIONS FOR THE DIAGNOSIS AND THERAPY OF DISEASES RELATED TO ANOMALICAL EXPRESSION OF FUTRINES (R-SPONDINES)
CN1902494B (en) * 2003-11-03 2010-10-27 伊西康公司 Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
GB0326393D0 (en) 2003-11-12 2003-12-17 Ares Trading Sa Cytokine antagonist molecules
WO2005070964A1 (en) * 2004-01-27 2005-08-04 Medical And Biological Laboratories Co., Ltd. Method of isolating monocytes
US20100031378A1 (en) 2008-08-04 2010-02-04 Edwards Joel A Novel gene disruptions, compositions and methods relating thereto
JP2007527712A (en) * 2004-02-12 2007-10-04 レキシコン・ジェネティクス・インコーポレーテッド Novel gene disruption, compositions and methods relating thereto
EP1771582A4 (en) * 2004-06-18 2008-04-16 Univ Duke Modulators of odorant receptors
AU2005267062C1 (en) * 2004-07-22 2013-01-17 Five Prime Therapeutics, Inc. Compositions and methods of use for MGD-CSF in disease treatment
WO2006072601A2 (en) * 2005-01-07 2006-07-13 Nsgene A/S THERAPEUTIC USE OF GROWTH FACTORS, NsG29 AND NsG31
GB0517466D0 (en) * 2005-08-26 2005-10-05 Immunodiagnostic Systems Plc Diagnostic assay and therapeutic treatment
US8088374B2 (en) 2006-10-20 2012-01-03 Deutsches Krebsforschungszentrum Stiftung Des Offenlichen Rechts Methods for inhibition of angiogenesis and vasculogenesis via rspondin antagonists
WO2008106709A1 (en) * 2007-03-07 2008-09-12 The Council Of The Queensland Institute Of Medical Research NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS
ES2537323T3 (en) 2007-08-20 2015-06-05 Oncotherapy Science, Inc. CDCA1 peptide and pharmaceutical agent comprising it
ES2629440T5 (en) 2007-10-04 2020-11-20 Zymogenetics Inc zB7H6 member of the B7 family and related compositions and methods
DK2656850T3 (en) 2007-10-05 2016-11-28 Index Pharmaceuticals Ab Oligonucleotides for the treatment or alleviation of EDEMA
JP5572938B2 (en) * 2007-10-25 2014-08-20 東レ株式会社 Immune inducer
CA2990264C (en) * 2007-10-25 2022-08-09 Toray Industries, Inc. Immune response inducer
ES2788152T3 (en) * 2007-10-25 2020-10-20 Toray Industries Method for detecting cancer
US9096689B2 (en) * 2007-11-07 2015-08-04 Northwestern University Methods and compositions for inhibiting angiogenesis
US8198406B2 (en) * 2007-11-07 2012-06-12 Northwestern University Methods and compositions for inhibiting angiogenesis
US20110053852A1 (en) * 2007-12-21 2011-03-03 Paul Klotman Use of podocan protein in treating cardiovascular diseases
TWI526219B (en) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Cdca1 epitope peptides and vaccines containing the same
US9687538B2 (en) 2012-07-10 2017-06-27 Oncotherapy Science, Inc. CDCA1 epitope peptides for Th1 cells and vaccines containing the same
CA2893977C (en) 2012-12-21 2024-02-13 Seattle Genetics, Inc. Anti-ntb-a antibodies and related compositions and methods
AU2016291846B2 (en) * 2015-07-13 2022-05-26 Compugen Ltd. HIDE1 Compositions and Methods
GB201520568D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
CN106047818A (en) * 2016-08-05 2016-10-26 武汉赛云博生物科技有限公司 Oncofetal antigen-specific TCR gene-modified T cell and cancer inhibition use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001265009A1 (en) * 2000-05-24 2001-12-03 Curagen Corporation Human polynucleotides and polypeptides encoded thereby

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of EP1556490A4 *
SELBY, M.J. ET AL.: "Analysis of a major human chorionic somatomammotropin gene", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 259, no. 10, 10 November 1984 (1984-11-10), pages 13131 - 13138, XP002304204 *

Also Published As

Publication number Publication date
JP2006517094A (en) 2006-07-20
EP1556490A2 (en) 2005-07-27
AU2003303305A1 (en) 2004-09-30
WO2004080148A2 (en) 2004-09-23
EP1556490A4 (en) 2006-04-05
CA2500521A1 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
WO2003054152A3 (en) Novel nucleic acids and polypeptides
WO2003025148A3 (en) Novel nucleic acids and polypeptides
WO2002070539A3 (en) Novel nucleic acids and polypeptides
WO2003023013A3 (en) Novel nucleic acids and polypeptides
WO2002081731A3 (en) Novel nucleic acids and polypeptides
WO2004080148A3 (en) Novel nucleic acids and polypeptides
WO2001075067A8 (en) Novel nucleic acids and polypeptides
WO2001057188A3 (en) Novel nucleic acids and polypeptides
WO2001057190A3 (en) Novel nucleic acids and polypeptides
WO2002022660A3 (en) Novel nucleic acids and polypeptides
WO2001066689A3 (en) Novel nucleic acids and polypeptides
WO2002031111A3 (en) Novel nucleic acids and polypeptides
WO2001088088A3 (en) Novel nucleic acids and polypeptides
WO2001053312A8 (en) Novel nucleic acids and polypeptides
WO2001053455A3 (en) Novel nucleic acids and polypeptides
WO2004009834A3 (en) Novel nucleic acids and secreted polypeptides
WO2002059260A3 (en) Nucleic acids and polypeptides
WO2003029271A3 (en) Novel nucleic acids and polypeptides
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2002018424A3 (en) Nucleic acids and polypeptides
WO2005047459A3 (en) Sars nucleic acids, proteins, antibodies, and uses thereof
WO2001079449A3 (en) Novel nucleic acids and polypeptides
WO2001002571A3 (en) An interleukin-1 receptor antagonist and uses thereof
EP1344827A3 (en) Antifreeze proteins from basidiomycetes
WO2003080795A3 (en) Novel nucleic acids and secreted polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003303305

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2500521

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004569415

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003815295

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003815295

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003815295

Country of ref document: EP